Latest in Biotech: Genentech and Mission Bay

Biotech: Genentech and Mission Bay at a glance

The 10 latest articles on Biotech: Genentech and Mission Bay come from 9 sources, published between Nov 4 and Nov 17. Most come from @PRNewswire (2).

People in these stories: Max Hodak (2), Murat Günel (2)

Organizations: FDA (3), Stanford (2), Science Corporation (2), Khosla Ventures (2), Ackman Oxman Institute (2), Tenet Healthcare (2)

Places: China (4), Europe (3), San Francisco (2), Berkeley (2), San Jose (2), Germany (2)

dev.to
798 words

$3.5B brain chip already lets blind patients read

#ai #biotech #neuroscience #discuss Science Corporation is worth $3.5 billion after a $400 million Series D — 2.3x its March valuation, eight months after raising $230 million at $1.5 billion. The number that matters more: its PRIMA chip is already CE-marked and restoring form vision in…

prnewswire.com
1,403 words

Tarsier Pharma Announces Results from a Phase 3 Clinical trial in Subjects with Noninfectious Anterior Uveitis Including Subjects with Uveitic Glaucoma

News provided by 23 Aug, 2023, 17:00 IDT TRS01 (eye drop formulation of dazdotuftide) demonstrates clear anti-inflammatory activity in noninfectious anterior uveitis with no evidence of significant adverse effects. A post hoc analysis looking at the drug total impact compared to steroids suggests a…

biospace.com
429 words

Link Biologics completes IND-enabling preclinical programme for LB001, a first-in-class novel therapy for dry eye disease

Completion of key IND-enabling activities represents a major development milestone for LB001 IND submission remains on track for Q1 2027, followed by initiation of a Phase 1/2 clinical study Manufacturing scale-up completed, providing supply for planned clinical studies LONDON, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Link Biologics…

Biotech: Genentech and Mission Bay

Genentech, Mission Bay's biotech cluster and Bay Area drug development.

  • 4 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.